Podcast

Share

Program Content

Activities

  • BTKi FAQ
    Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 31, 2022

    Expires: March 30, 2023

  • <i>Pearls</i>: BTKi FAQ
    Podcast Pearls: Expert Answers to Key Questions on Current and Emerging BTK Inhibitor Therapies for CLL and MCL
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 14, 2022

    Expires: April 13, 2023

Faculty

cover img faculity

Jeffrey P. DONOTUSESharman, MD

Medical Oncologist
Willamette Valley Cancer Institute and Research Center
Springfield, Oregon

cover img faculity

Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

cover img faculity

Matthew S. Davids, MD, MMSc

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research
Division of Lymphoma
Dana-Farber Cancer Institute
Boston, Massachusetts

cover img faculity

Anthony Mato, MD, MSCE

Associate Professor
Division of Leukemia
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

ProCE Banner

Supporters

Lilly